CENTENE CORP
CNCNYSE🏆 #429 by market capEarnings Oct 27 · PreUS Equity
$62.21▼ $0.32 (−0.52%)
🌙 After hours$62.21▲ 0.01%Regular close · extended-hours price shownTrack CNC
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d▼ 1.7%
14d▼ 8.0%
30d▼ 4.0%
ytd▲ 51.1%
1y▲ 76.5%
🏦Market Cap
$30.73B
Mid Cap
📈Revenue Growth (YoY)
+19.4%
Healthy
📊Gross Margin
16.1%
Thin
💵FCF Margin
4.6%
Moderate
⚖️P/S Ratio
0.2x
Cheap
Otter Score
72
Fair
CENTENE CORP
CNCAnalyst Ratings
Price
$62.21
Total
44
Raised
6
Lowered
5
Avg PT
$68.29
H / L
$80 / $39
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Argus Research | Upgraded | Hold → Buy | 2026-08-11 | $80.00 | +28.60% |
JP Morgan | Reiterated | Neutral | 2026-08-04 | $94.00 | +51.10% |
Bernstein | Reiterated | Outperform | 2026-08-03 | $79.00 | +27.00% |
Baird | Reiterated | Neutral | 2026-07-29 | — | — |
Barclays | Reiterated | Overweight | 2026-07-29 | $80.00 | +28.60% |
TD Cowen | Reiterated | Hold | 2026-07-14 | — | — |
Truist Securities | Reiterated | Buy | 2026-07-14 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2026-07-13 | $69.00 | +10.90% |
RBC Capital | Reiterated | Sector Perform | 2026-07-09 | $70.00 | +12.50% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-07 | $60.00 | −3.50% |
Mizuho | Reiterated | Neutral | 2026-06-08 | — | — |
B of A Securities | Reiterated | Buy | 2026-06-04 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-06-04 | $66.00 | +6.10% |
UBS | Reiterated | Neutral | 2026-05-22 | $79.00 | +27.00% |
Deutsche Bank | Upgraded | Hold → Buy | 2026-05-20 | $80.00 | +28.60% |
Oppenheimer | Reiterated | Outperform | 2026-04-29 | $58.00 | −6.80% |
Jefferies | Reiterated | Hold | 2026-04-20 | $39.00 | −37.30% |
Goldman Sachs | Reiterated | Sell | 2025-10-31 | $40.00 | −35.70% |
Guggenheim | Reiterated | Neutral | 2025-04-29 | — | — |
Stephens & Co. | Reiterated | Equal Weight | 2024-12-13 | — | — |
Stephens& Co. | Downgraded | Overweight → Equal Weight | 2024-03-21 | — | — |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2023-07-12 | $80.00 | +28.60% |
Credit Suisse | Reiterated | Outperform | 2023-04-26 | $104.00 | +67.20% |
Cowen & Co. | Reiterated | Outperform | 2023-02-14 | — | — |
Loop Capital | Reiterated | Buy | 2022-06-17 | — | — |
BMO Capital | Reiterated | Outperform | 2021-12-13 | — | — |
Seaport Global | Reiterated | Buy | 2021-07-09 | — | — |
Citigroup | Reiterated | Buy | 2021-06-17 | — | — |
SVB Leerink | Reiterated | Outperform | 2020-12-14 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-13 | — | — |
Leerink Swann | Upgraded | Market Perform → Outperform | 2018-10-24 | — | — |
Mitsubishi UFJ | Reiterated | Overweight | 2018-09-19 | — | — |
Bank of America | Reiterated | Buy | 2018-07-24 | — | — |
PiperJaffray | Reiterated | Overweight | 2017-01-04 | — | — |
Evercore ISI Group | Reiterated | Buy | 2016-09-23 | — | — |
Stifel Nicolaus | Upgraded | Hold → Buy | 2016-05-26 | $79.00 | +27.00% |
Stifel | Upgraded | Hold → Buy | 2016-05-26 | — | — |
FBR Capital | Upgraded | Market Perform → Outperform | 2015-07-13 | — | — |
Susquehanna | Reiterated | Positive | 2015-06-15 | — | — |
Sterne Agee | Reiterated | Buy | 2014-06-27 | — | — |
Monness Crespi Hardt | Downgraded | Buy → Neutral | 2013-10-23 | — | — |
Monness, Crespi, Hardt | Downgraded | Buy → Neutral | 2013-10-23 | — | — |
Lazard | Reiterated | Buy | 2013-06-27 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2013-05-24 | $75.00 | +20.60% |
Institution
Argus Research
Upgraded · Hold → Buy · 2026-08-11
$80.00
+28.60%
JP Morgan
Reiterated · Neutral · 2026-08-04
$94.00
+51.10%
Bernstein
Reiterated · Outperform · 2026-08-03
$79.00
+27.00%
Baird
Reiterated · Neutral · 2026-07-29
—
—
Barclays
Reiterated · Overweight · 2026-07-29
$80.00
+28.60%
TD Cowen
Reiterated · Hold · 2026-07-14
—
—
Truist Securities
Reiterated · Buy · 2026-07-14
—
—
Wells Fargo
Reiterated · Equal Weight · 2026-07-13
$69.00
+10.90%
RBC Capital
Reiterated · Sector Perform · 2026-07-09
$70.00
+12.50%
Cantor Fitzgerald
Reiterated · Overweight · 2026-07-07
$60.00
−3.50%
Mizuho
Reiterated · Neutral · 2026-06-08
—
—
B of A Securities
Reiterated · Buy · 2026-06-04
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-06-04
$66.00
+6.10%
UBS
Reiterated · Neutral · 2026-05-22
$79.00
+27.00%
Deutsche Bank
Upgraded · Hold → Buy · 2026-05-20
$80.00
+28.60%
Oppenheimer
Reiterated · Outperform · 2026-04-29
$58.00
−6.80%
Jefferies
Reiterated · Hold · 2026-04-20
$39.00
−37.30%
Goldman Sachs
Reiterated · Sell · 2025-10-31
$40.00
−35.70%
Guggenheim
Reiterated · Neutral · 2025-04-29
—
—
Stephens & Co.
Reiterated · Equal Weight · 2024-12-13
—
—
Stephens& Co.
Downgraded · Overweight → Equal Weight · 2024-03-21
—
—
Wolfe Research
Downgraded · Outperform → Peer Perform · 2023-07-12
$80.00
+28.60%
Credit Suisse
Reiterated · Outperform · 2023-04-26
$104.00
+67.20%
Cowen & Co.
Reiterated · Outperform · 2023-02-14
—
—
Loop Capital
Reiterated · Buy · 2022-06-17
—
—
BMO Capital
Reiterated · Outperform · 2021-12-13
—
—
Seaport Global
Reiterated · Buy · 2021-07-09
—
—
Citigroup
Reiterated · Buy · 2021-06-17
—
—
SVB Leerink
Reiterated · Outperform · 2020-12-14
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-04-13
—
—
Leerink Swann
Upgraded · Market Perform → Outperform · 2018-10-24
—
—
Mitsubishi UFJ
Reiterated · Overweight · 2018-09-19
—
—
Bank of America
Reiterated · Buy · 2018-07-24
—
—
PiperJaffray
Reiterated · Overweight · 2017-01-04
—
—
Evercore ISI Group
Reiterated · Buy · 2016-09-23
—
—
Stifel Nicolaus
Upgraded · Hold → Buy · 2016-05-26
$79.00
+27.00%
Stifel
Upgraded · Hold → Buy · 2016-05-26
—
—
FBR Capital
Upgraded · Market Perform → Outperform · 2015-07-13
—
—
Susquehanna
Reiterated · Positive · 2015-06-15
—
—
Sterne Agee
Reiterated · Buy · 2014-06-27
—
—
Monness Crespi Hardt
Downgraded · Buy → Neutral · 2013-10-23
—
—
Monness, Crespi, Hardt
Downgraded · Buy → Neutral · 2013-10-23
—
—
Lazard
Reiterated · Buy · 2013-06-27
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2013-05-24
$75.00
+20.60%
One row per institution · price target from the firm's latest published target